Healthcare
-
Beyond PTSD: Moral Injury Burdens Healthcare Workers
NEW YORK, July 21 — Most of us have a pretty good grasp on PTSD — the fear and hypervigilance that can…
-
States Rewrite Public Health Powers as Legislatures Curb Quarantine and Emergency Authority
WASHINGTON, July 18 — State legislatures are the primary engines of public health policy in America, yet their strategic importance on the…
-
Frederick Banting: Co-Discoverer of Insulin, Nobel Laureate
TORONTO, July 16 — Frederick Banting died in a plane crash in Newfoundland in 1941, but the insulin he helped drag out…
-
Multi-cancer blood tests show early promise, but doctors want proof they work
ROME, July 16 — The shift is happening in plain sight. Cancer detection is moving from single-organ biopsies to a single blood…
-
How insulin went from dog experiments in 1921 to modern diabetes treatment
WASHINGTON, July 16 — The Association for Diagnostics & Laboratory Medicine, the global scientific and medical professional organization formerly known as the…
-
Indiana Study Links Bowel Cancer Treatment Delays of 47 Days or More to Higher Spread Risk
BLOOMINGTON, July 15 — Researchers at the Indiana University School of Medicine have published a study that cuts through the usual clinical…
-
Colorectal cancer is rising in adults under 50 as many patients are told they are too young
INDIANAPOLIS, July 15 — A study published yesterday by researchers at the Indiana University School of Medicine is bringing new urgency to…
-
Ernexa Plans Fourth-Quarter First-in-Human Trial of ERNA-101 in Ovarian Cancer
SAN FRANCISCO, July 15 — Ernexa Therapeutics, a biotechnology company operating in the U.S. healthcare sector, is preparing to advance its lead…
-
Ernexa Moves ERNA-101 Into GMP Manufacturing Ahead of Planned IND Filing
KARACHI, July 15 — Ernexa Therapeutics is moving toward a planned first-in-human Phase 1 study for its lead cancer candidate, ERNA-101, though…
-
Bowel Cancer Five-Year Survival Falls From 91.5% at Early Stage to 16.2% at Stage 4
INDIANAPOLIS, July 15 — A study released yesterday by the Indiana University School of Medicine documents a stark divide in bowel cancer…
-
HDT Bio Takes Glioblastoma Immunotherapy HDT-401 Toward a Phase 1 Trial at McGill
MONTREAL, July 13 — McGill University has announced a new partnership with HDT Bio, a biotechnology firm, to advance clinical trials for…
-
Chinese Biotech Deals With Big Pharma Surge as Drugmakers Face Patent Cliff
BEIJING, July 13 — Cross-border deals for innovative drugs originating from China have reached a record US$110 billion in the first half…
-
Jammu and Kashmir reviews draft cancer care strategy to cut patient travel
SRINAGAR, July 13 — The Chief Secretary of Jammu and Kashmir, Atal Dulloo, chaired a high-level meeting here today to formulate a…
-
NYU AI Test Edges Out Oncotype DX in Predicting Breast Cancer Recurrence
NEW YORK, July 12 — A new AI tool from New York University may offer a cheaper alternative to genomic tests for…
-
Only 43 Antibiotics in Development as WHO Warns the Pipeline Falls Short
SINGAPORE, July 11 — For communities across Asia, the medicines that treat common infections are something many families take for granted. But…
-
Human Immune System: How It Defends the Body Against Pathogens,
WASHINGTON, July 10 — The human immune system operates as a coordinated network of cells, tissues, and organs that defends the body…
-
FDA Approves Breyanzi CAR-T Therapy for Relapsed Chronic Lymphocytic Leukemia
MANILA, July 7 — For families across the region watching loved ones battle blood cancers that keep returning, a new treatment option…
-
CAR-T Sales in 2023: Gilead’s Yescarta Led at $1.5 Billion as Kymriah Slipped
ISLAMABAD, July 7 — The global market for CAR-T cell therapy, a personalized cancer treatment that reprograms a patient’s own immune cells…
-
Strengthening Alberta’s Clinical Trial Infrastructure with New Funding
EDMONTON, July 7 — A significant investment in clinical trials is set to transform cancer care in Alberta, with the Alberta Cancer…
-
Personalized Vaccine Plus Immunotherapy Shows Promise in Advanced Head and Neck Cancer
NEW YORK, July 5, 2026 — For families facing a cancer diagnosis, the word “immunotherapy” has become a beacon of hope. The…
-
US Cancer Survival Rose From 49% to 69% Since 1975, but Gains Are Uneven
NEW YORK, July 5 — For families facing a cancer diagnosis, the language of treatment can feel like a foreign country. Words…
-
Global Cervical Cancer Treatment Market to Hit $14.43B by 2034
NEW YORK, July 3 — Behind every number in a market report is a person. A mother, a sister, a friend. That’s…
-
Oregon Emergency Doctors Use New State Law to Beat a National Staffing Company
MANILA — The emergency physicians who refused to be swallowed by a larger hospital system did not just win a legal fight.…
-
Father’s Hope Shattered as Rare Brain Cancer Returns
SOUTH SHIELDS, July 2 — A first-time father has been told he has up to 12 months to live after a routine…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992